Skip to main content
. Author manuscript; available in PMC: 2024 Jan 17.
Published in final edited form as: Drug Dev Res. 1996 Nov-Dec;39(3-4):253–261. doi: 10.1002/(sici)1098-2299(199611/12)39:3/4<253::aid-ddr4>3.0.co;2-q

Figure 3.

Figure 3.

Partial agonist activity of adenosine 3′-phosphate 5′-phosphosulfate. Turkey erythrocyte membranes were incubated with the indicated concentrations of 2MeSATP (filled circles) or adenosine 3′-phosphate 5′-phosphosulfate (open diamonds). Inositol phosphate accumulation was measured as a quantitation of PLC activity.